DCGI allows CMC Vellore to Conduct Trials on Mixing COVID Vaccines
The Department of Biotechnology secretary, Dr Swarup, stated that the DCGI has approved CMC Vellore to begin a study on the combination of Covid-19 vaccines.
COVID-19 Vaccines: The Drugs Controller General of India (DCGI) has approved the Christian Medical College (CMC) Vellore to begin a study on the combination of COVID-19 vaccines, the Centre said on Tuesday. Dr Renu Swarup, Secretary of the Department of Biotechnology, said, "A couple of such studies have been initiated," "We need more scientific data to get more clarity," she continued.
Dr Swarup revealed that the Covid-19 vaccine, developed by the Hyderabad-based Biological E, is in the final stages of testing.
Biological E is expected to submit results for phase 1 and 2 clinical trials for emergency use authorisation of its coronavirus vaccine, Corbevax, by the end of September or early October, according to sources.
